Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04066699 · ClinicalTrials.gov registry record
Percutaneous Localization: Open-label Registry of Thoracic Surgery
A clinical trial, sponsored by Veran Medical Technologies.
- Completed
- Registry status
- 70
- Enrollment target
NCT04066699: Completed study, sponsored by Veran Medical Technologies.
NCT04066699 is a clinical trial that has completed, run by Veran Medical Technologies. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04066699 has completed, sponsored by Veran Medical Technologies.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
Study Summary
The objectives of this study are to evaluate intraoperative percutaneous lung lesion marking assisted by electromagnetic guided percutaneous navigation and related tools.
Interventions
- PROCEDURE Percutaneous localization of suspicious lung lesion(s) using electromagnetic navigation and tools.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2019-10-10 |
| Est. Completion | 2023-02-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04066699
The ClinicalTrials.gov registry entry for NCT04066699 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Veran Medical Technologies, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Percutaneous localization of suspicious lung lesion(s) using electromagnetic navigation and tools. is the first listed.
NCT04066699 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04066699 about?
NCT04066699 is a clinical study titled "Percutaneous Localization: Open-label Registry of Thoracic Surgery". The objectives of this study are to evaluate intraoperative percutaneous lung lesion marking assisted by electromagnetic guided percutaneous navigation and related tools.
What is the current status of trial NCT04066699?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2019-10-10. Estimated completion is 2023-02-09.
What interventions are being tested in trial NCT04066699?
The interventions under investigation include: Percutaneous localization of suspicious lung lesion(s) using electromagnetic navigation and tools. (PROCEDURE).
Who is sponsoring clinical trial NCT04066699?
This trial is sponsored by Veran Medical Technologies, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.